Featured Research

from universities, journals, and other organizations

New Laser For Neurosurgery Allows Greater Precision And Efficiency For Removal Of Complex Tumors

Date:
February 1, 2009
Source:
Northwestern Memorial Hospital
Summary:
Surgeons have started using a new micro-laser, which uses light energy in place of a cutting tool to remove complicated brain and spine tumors. The technique offers greater precision and efficiency during surgery, reducing the incision size, surgery time and patient recovery period following surgery.

Surgeons at Northwestern Memorial Hospital are among the first in the country to use a new micro-laser, which uses light energy in place of a cutting tool to remove complicated brain and spine tumors. The technique offers greater precision and efficiency during surgery, reducing the incision size, surgery time and patient recovery period following surgery.

Surgeons first used the laser in October when Stephen Abbott, a 70-year-old retired United States Army officer, presented with a brain tumor the size of a plum attached to one of the major veins draining blood from the brain. The tumor was discovered during a routine physical earlier in the year when a test indicated Mr. Abbott was experiencing some hearing loss.

Bernard Bendok, MD, a vascular and skull base neurosurgeon and Andrew Fishman, MD, a neurootologist and skull base surgeon, collaborated on the case and determined that Mr. Abbott was a prime candidate for surgery. The two then merged their specialties to operate on the complex tumor, using the laser, to help them remove the tumor quickly and safely. The removal of the tumor took less than one hour and after just five days Mr. Abbott was home, healthy and back to his daily routine.

The laser, called the BeamPath NEURO™, allows surgeons to direct CO2 laser energy into deep holes and around blood vessels and other specific nerve structures and the brainstem. It is designed for operating near critical structures in the brain and spine and is used in place of a scalpel to cut tissue and remove tumors.

“When lasers were first used in neurosurgery some 30 years ago, surgeons were very excited, but it faded quickly because the devices were too cumbersome,” commented Dr. Bendok. “This new tool provides far greater control and precision in tight surgical corridors”

“The laser enables us to be much more efficient during surgery, we are able to remove tumors much more quickly which shortens overall surgery time,” commented Dr. Fishman. “That translates into a quicker recovery for patients.”


Story Source:

The above story is based on materials provided by Northwestern Memorial Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern Memorial Hospital. "New Laser For Neurosurgery Allows Greater Precision And Efficiency For Removal Of Complex Tumors." ScienceDaily. ScienceDaily, 1 February 2009. <www.sciencedaily.com/releases/2009/01/090128132654.htm>.
Northwestern Memorial Hospital. (2009, February 1). New Laser For Neurosurgery Allows Greater Precision And Efficiency For Removal Of Complex Tumors. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/01/090128132654.htm
Northwestern Memorial Hospital. "New Laser For Neurosurgery Allows Greater Precision And Efficiency For Removal Of Complex Tumors." ScienceDaily. www.sciencedaily.com/releases/2009/01/090128132654.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins